Aflibercept shows promise in polypoidal choroidal vasculopathy
Patients with polypoidal choroidal vasculopathy may benefit from intravitreal aflibercept.Patients with polypoidal choroidal vasculopathy may benefit from intravitreal aflibercept (Eylea, Bayer...
View ArticleComparing anti-VEGFs for DME
In a 1-year comparison of intravitreous aflibercept, bevacizumab and ranibizumab therapy for centre-involved diabetic macular oedema (DME), aflibercept was more effective at improving vision among...
View ArticleClik here to view.
High-res device gives retinal imaging a facelift
Rochester, NY—Retinal disease has been given a new face thanks to increased details of the adaptive optics scanning laser ophthalmoscope (AO-SLO), according to Mina Chung, MD. Did you see this? Top 10...
View ArticleClik here to view.
Ranibizumab achieves higher BCVA gains for BRVO in COMRADE-B
Take-home message: In this article, Dr Simon Taylor discusses results of the key studies for both the ranibizumab anti-VEGF injection and the dexamethasone implant, including the higher BCVA gains...
View ArticleClik here to view.
Lasting effects of anti-VEGF/photodynamic therapy for AMD
Take-home message: The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible...
View ArticleClik here to view.
Real-world experience: Positive DME treatment outcomes observed with FAc...
Take-home message: Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and...
View ArticleClik here to view.
Real-world experience: Case study shows maintained benefits with FAc in DME...
Take-home message: In the case study discussed in this article, a patient who was treated for DME with a fluocinolone acetonide intravitreal implant reported improved vision-related quality of life...
View ArticleClik here to view.
Dexamethasone for DME shows stronger results compared with sham group
Take-home message: In this article Dr Anat Lowenstein explains that the benefits of treatment with a dexamethasone intravitreal implant for DME were observed across a variety of demographic...
View ArticleDRCR.net retinal treatment results take center stage in 2015
Reviewed by Julia A. Haller, MD, Mary Elizabeth Hartnett, MD, and Carl Regillo, MD Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug...
View Article
